Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.32 USD | -2.86% | -1.38% | -20.33% |
05-10 | UBS Cuts Price Target on Arrowhead Pharmaceuticals to $71 From $75, Keeps Buy Rating | MT |
05-09 | Arrowhead Pharmaceuticals Swings to Loss in Fiscal Q2 | MT |